Table 2.
Comparison of the biometric parameters of the eyes and inflammatory markers in patients with primary angle-closure glaucoma (PACG) and control subjects.
| Parameter | Control eyes |
PACG eyes |
Z/F | Statistical analyses | ||
|---|---|---|---|---|---|---|
| Eyes, n | Eyes, n | |||||
| ACD | 37 | 2.46 (2.26–2.70) | 62 | 1.70 (1.49–1.95) | –6.930 | P < 0.001* |
| ACV | 37 | 114.00 (93.50–137.50) | 62 | 58.50 (51.00–68.25) | –6.084 | P < 0.001* |
| AL | 37 | 23.41 (22.89–22.99) | 62 | 22.32 (22.21–22.66) | –5.602 | P < 0.001* |
| CMT | 37 | 213.00 (202.00–225.00) | 62 | 209.5 (194.00–220.50) | –0.659 | NS* |
| CV | 37 | 58.40 ± 4.31 | 62 | 58.62 ± 6.08 | 4.186 | NS |
| MCC/K | 37 | 44.27 ± 1.42 | 62 | 45.16 ± 2.34 | 8.098 | P = 0.039 |
| LT | 37 | 4.32 ± 0.50 | 62 | 4.87 ± 0.28 | 11.812 | P < 0.001 |
| CD | 37 | 11.32 ± 0.40 | 62 | 11.02 ± 0.41 | 0.032 | P < 0.001 |
| CT | 37 | 537.27 ± 33.58 | 62 | 533.32 ± 37.89 | 0.050 | NS |
| SFCT | 37 | 151.11 ± 29.44 | 62 | 173.11 ± 34.45 | 1.001 | P = 0.002 |
| Interleukin-6, pg/ml | 32 | 2.16 (2.00–6.81) | 31 | 1.50 (1.50–1.71) | –5.280 | P < 0.001* |
| Neutrophil-to-lymphocyte ratio | 32 | 1.56 (1.17–2.89) | 31 | 2.23 (1.80–3.00) | 2.331 | P = 0.020* |
| Tumour necrosis factor-α, pg/ml | 32 | 5.63 (3.31–11.04) | 31 | 5.63 (3.31–11.04) | –0.098 | NS* |
Data presented as mean ± SD or median (interquartile range).
*Kruskal–Wallis; independent samples t-test was used for the other comparisons; NS, no significant between-group difference (P ≥ 0.05).
ACD, anterior chamber depth; ACV, anterior chamber volume; AL, axial length; CMT, central macular thickness; CV, corneal volume; MCC/K, mean corneal curvature; LT, lens thickness; CD, corneal diameter; CT, corneal thickness; SFCT, subfoveal choroidal thickness.